Liposomal hypocrellin B as a potential photosensitizer for age-related macular degeneration: Pharmacokinetics, photodynamic efficacy, and skin phototoxicity in vivo

Photochemical and Photobiological Sciences

Volumn 14, Issue 5, 2015, Pages 972-981

  Li, Tinghui ^a   Hou, Xiaobin ^b   Deng, Hong ^c   Zhao, Jingquan ^c   Huang, Naiyan ^b   Zeng, Jing ^b   Chen, Hongxia ^b   Gu, Ying ^b  

^a Department of Dermatology ^*  (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MUS; RATTUS;

HYPOCRELLIN B; LIPOSOME; PERYLENE; PHOTOSENSITIZING AGENT; QUINONE DERIVATIVE;

ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; EAR; ENDOTHELIUM CELL; FEMALE; LUNG; MALE; MICROVASCULATURE; MOUSE; ORGAN SIZE; PATHOLOGY; PHOTOCHEMOTHERAPY; PHYSIOLOGY; PROCEDURES; RADIATION RESPONSE; RAT; RETINA; SKIN; SUBRETINAL NEOVASCULARIZATION; SYNTHESIS; VASCULARIZATION; WET MACULAR DEGENERATION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EAR; ENDOTHELIAL CELLS; FEMALE; LIPOSOMES; LUNG; MALE; MICE; MICROVESSELS; ORGAN SIZE; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; QUINONES; RATS; RETINA; SKIN; WET MACULAR DEGENERATION;

EID: 84929161810     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/c4pp00412d     Document Type: Article

References (53)

1. T. Y. Wong U. Chakravarthy R. Klein P. Mitchell G. Zlateva R. Buggage K. Fahrbach C. Probst I. Sledge The natural history and prognosis of neovascular age-related macular degeneration: A systematic review of the literature and meta-analysis Ophthalmology 2008 115 116 126
2. J. Ambati B. K. Ambati S. H. Yoo S. Lanchulev A. P. Adamis Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies Surv. Ophthalmol. 2003 48 257 293
3. H. E. Grossniklaus W. R. Green Choroidal neovascularization Am. J. Ophthalmol. 2004 137 496 503
4. H. R. Coleman C. C. Chan F. L. Ferris E. Y. Chew Age-related macular degeneration Lancet 2008 372 1835 1845
5. D. M. Brown P. K. Kaiser M. Michels G. Soubrane J. S. Heier R. Y. Kim J. P. Sy S. Schneider ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N. Engl. J. Med. 2006 355 1432 1444
6. D. F. Martin M. G. Maguire G. S. Ying J. E. Grunwald S. L. Fine G. J. Jaffe CATT Research Group Ranibizumab and bevacizumab for neovascular age-related macular degeneration N. Engl. J. Med. 2011 364 1897 1908
7. N. Jo C. Mailhos M. H. Ju E. Cheung J. Bradley K. Nishijima G. S. Robinson A. P. Adamis D. T. Shima Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization Am. J. Pathol. 2006 168 2036 2053
8. D. J. Browning P. K. Kaiser P. J. Rosenfeld M. W. Stewart Aflibercept for age-related macular degeneration: A game-changer or quiet addition? Am. J. Ophthalmol. 2012 154 222 226
9. T. Y. Wong G. Tikellis C. Sun R. Klein D. J. Couper A. R. Sharrett Age-related macular degeneration and risk of coronary heart disease-the atherosclerosis risk in communities study Ophthalmology 2007 114 86 91
10. J. Tunon J. M. Ruiz-Moreno J. L. Martin-Ventura L. M. Blanco-Colio O. Lorenzo J. Egido Cardiovascular risk and anti-angiogenic therapy for age-related macular degeneration Surv. Ophthalmol. 2009 54 339 3488
11. L. H. Curtis B. G. Hammill K. A. Schulman S. W. Cousins Risks of mortality, myocardial Infarction, bleeding, and stroke associated with therapies for age-related macular degeneration Arch. Ophthalmol. 2010 128 1273 1279
12. N. M. Bressler Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report Arch. Ophthalmol. 1999 117 1329 1345
13. N. M. Bressler Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2 Arch. Ophthalmol. 2001 119 198 207
14. M. Varano P. Iacono P. Giorno A. Chiaravalloti M. Parravano Photodynamic therapy in subfoveal and juxtafoveal myopic choroidal neovascularization: a 10-year retrospective analysis Ophthalmologica 2014 231 204 210
15. S. Yano S. Hirohara M. Obata Y. Hagiya S. Ogura A. Ikeda H. Kataoka M. Tanaka T. Joh Current states and future views in photodynamic therapy J. Photochem. Photobiol., C 2011 12 46 67
16. N. Thomas L. Tirand E. Chatelut F. Plenat C. Frochot M. Dodeller F. Guillemin M. Barberi-Heyob Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice Photochem. Photobiol. Sci. 2008 7 433 441
17. B. Aveline T. Hasan R. W. Redmond Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring-a (Bpd-Ma) Photochem. Photobiol. 1994 59 328 335
18. S. Stolik J. A. Delgado A. Perez L. Anasagasti Measurement of the penetration depths of red and near infrared light in human "ex vivo" tissues J. Photochem. Photobiol., B 2000 57 90 93
19. J. J. Arnold K. J. Blinder M. Bressler S. B. Bressler A. Burdan L. Haynes J. I. Lim J. W. Miller M. J. Potter A. Reaves P. J. Rosenfeld M. Sickenberg J. S. Slakter G. Soubrane H. A. Strong M. Stur Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group and Verteporfin in Photodynamic Therapy Study Group Acute severe visual acuity decrease after photodynamic therapy with verteporfin: Case reports from randomized clinical trials-TAP and VIP report no. 3 Am. J. Ophthalmol. 2004 137 683 696
20. R. Tzekov T. Lin K. M. Zhang B. Jackson A. Oyejide W. Orilla A. D. Kulkarni B. D. Kuppermann L. Wheeler J. Burke Ocular changes after photodynamic therapy Invest. Ophthalmol. Vis. Sci. 2006 47 377 385
21. H. Ozdemir S. A. Karacorlu M. Karacorlu Early optical coherence tomography changes after photodynamic therapy in patients with age-related macular degeneration Am. J. Ophthalmol. 2006 141 574 576
22. E. P. Estey K. Brown Z. J. Diwu J. X. Lin J. W. Lown G. G. Miller R. B. Moore J. Tulip M. S. McPhee Hypocrellins as photosensitizers for photodynamic therapy: A screening evaluation and pharmacokinetic study Cancer Chemother. Pharmacol. 1996 37 343 350
23. B. Khoobehi R. Grinstead E. Passos Experimental photodynamic effects of hypocrellin A on the choriocapillaris Ophthalmic Surg. Lasers 2002 33 207 213
24. L. J. Jiang Y. Y. He Photophysics, photochemistry and photobiology of hypocrellin photosensitizers Chin. Sci. Bull. 2001 46 6 16
25. G. G. Miller K. Brown A. M. Ballangrud O. Barajs Z. Xiao J. Tulip J. W. Lown J. M. Leithoff M. J. Allalunis Turner R. D. Mehta R. B. Moore Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: Progress update Photochem. Photobiol. 1997 65 714 722
26. S. H. Barsky S. Rosen D. E. Geer J. M. Noe Nature and evolution of port wine stains-computer-assisted study J. Invest. Dermatol. 1980 74 154 157
27. C. K. Leung W. M. Chan K. K. Chong K. C. Chan W. H. Yung M. K. Tsang R. K. Tse D. S. Lam Alignment artifacts in optical coherence tomography analyzed images Ophthalmology 2007 114 263 270
28. J. Q. Zhao H. Deng J. Xie X. Liu Y. Zhang N. Y. Huang Y. Gu Towards characteristics of photodynamic drugs specifically aimed at microvascular diseases Mini-Rev. Med. Chem. 2010 10 332 341
29. H. Deng X. Liu J. Xie R. Yin N. Y. Huang Y. Gu J. Q. Zhao Quantitative and site-directed chemical modification of hypocrellins toward direct dug delivery and effective photodynamic activity J. Med. Chem. 2012 55 1910 1919
30. S. J. Xu X. X. Zhang S. Chen M. H. Zhang T. Shen Z. P. Wang Novel phototherapeutic agents: Investigation and progress of hypocrellin derivatives Chin. Sci. Bull. 2003 48 1775 1785
31. S. Q. Xia J. H. Zhou J. R. Chen X. S. Wang B. W. Zhang A tyrosine-modified hypocrellin B with affinity for and photodamaging ability towards calf thymus DNA Chem. Commun. 2003 2900 2901
32. Z. H. Zeng R. Qiao J. H. Zhou S. Q. Xia Y. Zhang Y. Y. Liu J. R. Chen X. S. Wang B. W. Zhang Photodynamic properties of dipeptide-modified hypocrellin B derivatives: The role of tyrosine and tryptophan groups J. Phys. Chem. B 2007 111 3742 3749
33. Y. Y. Liu Q. X. Zhou Z. H. Zeng R. Qiao X. S. Wang B. W. Zhang Photodynamic properties of a bispyrrolecarboxamide-modified hypocrellin B: The role of affinity and ascorbic acid J. Phys. Chem. B 2008 112 9959 9965
34. Z. X. Zhou L. N. Zhang H. M. Liu Q. Zhang B. Y. Liu P. Ai H. T. Ma W. Liu Z. L. Li W. Sheng Y. Zeng R. G. Zhong Photocytotoxicity of hypocrellin B (HB) was enhanced by liposomalization in vitro Int. J. Toxicol. 2011 30 174 180
35. C. L. Yu S. Chen M. H. Zhang T. Shen Spectroscopic studies and photodynamic actions of hypocrellin B in liposomes Photochem. Photobiol. 2001 3 482 488
36. H. X. Chen Z. F. Yang X. B. Zou J. G. Zhu H. Deng J. Q. Zhao Y. Gu Photodynamic efficacy of liposome-delivered hypocrellin B in microvascular endothelial cells in vitro and chicken combs in vivo: a potential photosensitizer for port wine stain Laser Phys. 2013 23 025605
37. F. G. Liu L. N. Han Y. Gu L. Zhang H. X. Chen Biological features of the choriocapillaries after hypocrellin B photodynamic therapy Chin. J. Clin. Rehabil. 2005 9 254 256
38. K. H. Zhao L. J. Jiang Conversion of hypocrellin A in alkaline and neutral media Chin. J. Org. Chem. 1989 9 252 254
39. M. Brandl D. Bachmann M. Drechsler K. H. Bauer Liposome preparation by a new high-Pressure homogenizer gaulin micron lab-40 Drug Dev. Ind. Pharm. 1990 16 2167 2191
40. D. N. Zacks E. Ezra Y. Terada N. Michaud E. Connolly E. S. Gragouda J. W. Miller Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization Invest. Ophthalmol. Vis. Sci. 2002 43 2384 2391
41. B. T. Paul M. S. Babu T. R. Santhoshkumar D. Karunagaran G. S. Selvam K. Brown T. Woo S. Sharma S. Naicker R. Murugesan Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agents J. Photochem. Photobiol., B 2009 94 38 44
42. M. A. Mainster Wavelength selection in macular photocoagulation-tissue optics, thermal Effects, and laser systems Ophthalmology 1986 93 952 958
43. B. Katz J. McBean J. S. Cheung The new laser liposuction for men Dermatol. Ther. 2007 20 448 451
44. J. H. Lock K. C. Fong An update on retinal laser therapy Clin. Exp. Optom. 2011 94 43 51
45. H. Deng T. H. Li J. Xie N. Y. Huang Y. Gu J. Q. Zhao Synthesis and bio-evaluation of novel hypocrellin derivatives: Potential photosensitizers for photodynamic therapy of age-related macular degeneration Dyes Pigm. 2013 99 930 939
46. C. Sunderkotter K. Steinbrink M. Goebeler R. Bhardwaj C. Sorg Macrophages and Angiogenesis J. Leukocyte Biol. 1994 55 410 422
47. S. Piermarocchi M. Sartore G. Lo Giudice G. Monterosso E. Pilotto T. Segato Is there any relationship between photodynamic therapy for exudative age-related macular degeneration and choroidal neovascularization recurrence? A rationale for combined treatments Eur. J. Ophthalmol. 2006 16 686 694
48. M. Berdugo R. A. Bejjani F. Valamanesh M. Savoldelli J. C. Jeanny D. Blanc H. Ficheux A. Scherz Y. Salomon D. BenEzra F. Behar-Cohen Evaluation of the new photosensitizer stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes Invest. Ophthalmol. Vis. Sci. 2008 49 1633 1644
49. X. D. Huang D. G. Dixon B. M. Greenberg Increased polycyclic aromatic hydrocarbon toxicity following their photomodification in natural sunlight-impacts on the duckweed lemna-gibba L G-3 Ecotoxicol. Environ. Saf. 1995 32 194 200
50. M. D. Bilgin A. E. Elcin Y. M. Elcin Topical use of liposomal copper palmitate formulation blocks porphyrin-induced photosensitivity in rats J. Photochem. Photobiol., B 2005 80 107 114
51. T. C. Zhu J. C. Finlay The role of photodynamic therapy (PDT) physics Med. Phys. 2008 35 3127 3136
52. S. T. Wolford D. L. Novicki B. Kelly Comparative skin phototoxicity in mice with 2 photosensitizing drugs-benzoporphyrin derivative monoacid ring-a and porfimer sodium (Photofrin) Fundam. Appl. Toxicol. 1995 24 52 56
53. D. A. Bellnier W. R. Greco H. Nava G. M. Loewen A. R. Oseroff T. J. Dougherty Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy Cancer Chemother. Pharmacol. 2006 57 40 45